Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Recurrent Miscarriage (BBQ)
NCT03165136Phase 3Active, not recruiting
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Dec 2017
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of hydroxychloroquine in recurrent miscarriage (RPL), sponsored by Centre Hospitalier Universitaire de Brest. Started Dec 2017; status: active, not recruiting.
02
Drugs
hydroxychloroquine
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on NCT03165136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03165136.